Retraction notices

A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and beta-cell function.

Type

Expression of concern

Notice date

5/17/2018 0:00

Journal

Expert Opinion on Pharmacotherapy

Publisher

Taylor and Francis

Notice DOI

10.1080/14656566.2018.1475338

Original paper DOI

10.1517/14656566.2012.730519

Reasons

• Duplication of/in Article
• Investigation by Journal/Publisher

Matching venue names

Name match only, not an authoritative journal identifier.

• Expert Opinion on Pharmacotherapy